Clinical Trials
Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced updates on its Phase 3 clinical development program of NVX-CoV2373, its...
Clinical Trials
Boehringer Ingelheim Begins Phase 2 Clinical Trial of a...
Boehringer Ingelheim announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of TRPC6, a receptor-operated cation channel. This potent and...
Clinical Trials
Kintor Pharmaceutical’s COVID-19 Clinical Trials for Proxalutamide to expand...
Kintor Pharmaceutical Limited is delighted to announced that the clinical trial of anti-androgen treatment Proxalutamide (GT0918) for the novel coronavirus disease (COVID-19) has reached the...
Clinical Trials
Global Coalition for Adaptive Research, Amgen, and Eisai Announce...
The Global Coalition for Adaptive Research (GCAR) in collaboration with Amgen and Eisai Co., Ltd., announced enrollment of the first patient in the immune modulation...
Clinical Trials
AbbVie to Present New Analyses from Pivotal Phase 3...
AbbVie at the 29th European Academy of Dermatology and Venereology (EADV) Virtual Congress show that significantly more atopic dermatitis patients treated with upadacitinib (15 mg...
Clinical Trials
Baxter Supports New Study Showing Blood Purification with Oxiris...
Baxter International Inc., a global leader in acute care, recognizes the findings of a prospective, multicenter, observational study on data from the OxirisNet Registry evaluating...
Clinical Trials
LabCorp Transforms the Clinical Trial Experience And Streamlines the...
LabCorp , a leading global life sciences company that is focused on advancing health and guiding patient care decisions, announced new capabilities that will transform...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.